A study in the October issue of Gastroenterology assessed the ability of candidate biomarkers to predict which cases of Barrett's esophagus will progress to esophageal adenocarcinoma or high-grade dysplasia, and identified those that can be measured in formalin-fixed tissues. Dr. Kuemmerle speaks to  author Dr. Rebecca C. Fitzgerald of the Hutchison-MRC Research Centre, Cambridge, United Kingdom; Plus, a rundown of top stories from this month's issue of GI and Hepatology News.